Trial NCT00879229

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-300-0128

Last trial update was posted on 2014-05-15

MeSH Interventions

Ambrisentan

MeSH Conditions

Fibrosis Hypertension Hypertension, Pulmonary Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis

Other Conditions

Pulmonary Hypertension

Stopping Reasons

N/A

Limitations And Caveats

Study GS-US-300-0128 was terminated early with enrollment of 40 of 225 planned subjects.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID